Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD

January 17, 2024

https://www.globenewswire.com/news-release/2024/01/16/2809826/0/en/Message-from-Renovaro-Bioscience-Inc-s-CEO-The-Hon-Mark-Dybul-MD.html

LOS ANGELES, Jan. 16, 2024 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (Nasdaq:RENB)

Dear Shareholders,

Happy New Year.

I write to update you on our key developments towards precision medicine for healthy longevity – starting with cancer – powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery towards our vision of a world with effective cancer treatments free from toxic chemotherapy.

Read more at globenewswire.com

Related news for (RENB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.